Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07226271 · ClinicalTrials.gov registry record · NA

Consumer Perceptions of Alcoholic Beverages

A NA study of Health Behavior, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target
1
Study location

NCT07226271: Recruiting NA study of Health Behavior, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT07226271 is a NA study of Health Behavior that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,500 participants, below the 2,163-participant average among 65 other Health Behavior trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07226271, a NA study of Health Behavior, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine the effects of marketing claims on alcoholic beverage packaging on alcohol consumers' perceptions and intentions. Participants will be randomized to view three images of alcoholic beverages (beer, hard seltzer, flavored malt beverage) with one of three marketing claims (or a no claim control), and then queried about their perceptions of the product and intentions to consume the product.

Primary Outcome

Measured using four survey items: 1.) "How open are you to trying this drink in the next two weeks?" 2.) "How open are you to buying this drink in the next two weeks? " 3.) "How open are you to consuming one serving of this drink in the next two weeks? One serving of this product is one 12 ounce can or bottle." and 4.) "How open are you to drinking x servings of this drink in one sitting in the next two weeks?" where x = 4 if the participant's gender is female, 5 otherwise Response options are o

Conditions Studied

Interventions

  • BEHAVIORAL Natural Claim
  • BEHAVIORAL Sugar Claim
  • BEHAVIORAL Fruit Claim

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology - Chapel Hill

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-10-10
Est. Completion 2026-09-17
Phase NA

What NCT07226271 shows while recruiting

NCT07226271 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 2,163-participant average among 65 other Health Behavior trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 3 interventions - of which Natural Claim is the first listed.

NCT07226271 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07226271 about?

NCT07226271 is a clinical study titled "Consumer Perceptions of Alcoholic Beverages". This study aims to examine the effects of marketing claims on alcoholic beverage packaging on alcohol consumers' perceptions and intentions. Participants will be randomized to view three images of alcoholic beverages (beer, hard seltzer, flavored malt beverage) with one of three marketing claims (or...

What is the current status of trial NCT07226271?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2025-10-10. Estimated completion is 2026-09-17.

What conditions does trial NCT07226271 study?

This clinical trial studies the following conditions: Health Behavior.

What interventions are being tested in trial NCT07226271?

The interventions under investigation include: Natural Claim (BEHAVIORAL), Sugar Claim (BEHAVIORAL), Fruit Claim (BEHAVIORAL).

Who is sponsoring clinical trial NCT07226271?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07226271 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07226271's enrollment target sits among peer trials

1,500 10th of 65 higher than 56 of 65 other Health Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07226271, the US trial registry maintained by the National Library of Medicine. NCT07226271 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.